277 related articles for article (PubMed ID: 17702177)
1. [Patients with clinically unconfirmed positive urinary cytology --retrospective analysis of clinical courses].
Kurimura Y; Takahashi A; Hirobe M; Kunishima Y; Masumori N; Matsukawa M; Ito N; Tsukamoto T
Hinyokika Kiyo; 2007 Jul; 53(7):455-8. PubMed ID: 17702177
[TBL] [Abstract][Full Text] [Related]
2. Quick-staining urinary cytology and bladder wash image analysis with an integrated risk classification: a worthwhile improvement in the follow-up of bladder cancer?
Wiener HG; Remkes GW; Schatzl G; Susani M; Breitenecker G
Cancer; 1999 Oct; 87(5):263-9. PubMed ID: 10536351
[TBL] [Abstract][Full Text] [Related]
3. Combined morphologic and fluorescence in situ hybridization analysis of voided urine samples for the detection and follow-up of bladder cancer in patients with benign urine cytology.
Daniely M; Rona R; Kaplan T; Olsfanger S; Elboim L; Freiberger A; Lew S; Leibovitch I
Cancer; 2007 Dec; 111(6):517-24. PubMed ID: 17963263
[TBL] [Abstract][Full Text] [Related]
4. Indications for ureteropyeloscopy based on radiographic findings and urine cytology in detection of upper urinary tract carcinoma.
Takao A; Saika T; Uehara S; Monden K; Abarzua F; Nasu Y; Kumon H;
Jpn J Clin Oncol; 2010 Nov; 40(11):1087-91. PubMed ID: 20581003
[TBL] [Abstract][Full Text] [Related]
5. Clinically unconfirmed positive urinary cytology: diagnostic implications and oncological outcomes.
Aharony S; Baniel J; Yossepowitch O
BJU Int; 2011 Oct; 108(8 Pt 2):E179-83. PubMed ID: 21615850
[TBL] [Abstract][Full Text] [Related]
6. Surveillance of patients with bladder carcinoma using fluorescent in-situ hybridization on bladder washings.
Bergman J; Reznichek RC; Rajfer J
BJU Int; 2008 Jan; 101(1):26-9. PubMed ID: 17850364
[TBL] [Abstract][Full Text] [Related]
7. Reflex UroVysion testing of bladder cancer surveillance patients with equivocal or negative urine cytology: a prospective study with focus on the natural history of anticipatory positive findings.
Yoder BJ; Skacel M; Hedgepeth R; Babineau D; Ulchaker JC; Liou LS; Brainard JA; Biscotti CV; Jones JS; Tubbs RR
Am J Clin Pathol; 2007 Feb; 127(2):295-301. PubMed ID: 17210520
[TBL] [Abstract][Full Text] [Related]
8. Hexylaminolaevulinate 'blue light' fluorescence cystoscopy in the investigation of clinically unconfirmed positive urine cytology.
Ray ER; Chatterton K; Khan MS; Thomas K; Chandra A; O'Brien TS
BJU Int; 2009 May; 103(10):1363-7. PubMed ID: 19076151
[TBL] [Abstract][Full Text] [Related]
9. uCyt+ test: alternative to cystoscopy for less-invasive follow-up of patients with low risk of urothelial carcinoma.
Lodde M; Mian C; Comploj E; Palermo S; Longhi E; Marberger M; Pycha A
Urology; 2006 May; 67(5):950-4. PubMed ID: 16698355
[TBL] [Abstract][Full Text] [Related]
10. [Evaluation of urinary cytology for upper urinary tract disease].
Takeuchi T; Shinoda I; Kuriyama M; Kobayashi S; Nagatani Y; Komeda H; Takahashi Y; Saito A; Chang PK; Kanematsu M
Hinyokika Kiyo; 1986 Feb; 32(2):177-82. PubMed ID: 3728224
[TBL] [Abstract][Full Text] [Related]
11. The diagnostic accuracy of sputum and urine cytology.
Kern WH
Acta Cytol; 1988; 32(5):651-4. PubMed ID: 3421012
[TBL] [Abstract][Full Text] [Related]
12. UroVysion compared with cytology and quantitative cytology in the surveillance of non-muscle-invasive bladder cancer.
Moonen PM; Merkx GF; Peelen P; Karthaus HF; Smeets DF; Witjes JA
Eur Urol; 2007 May; 51(5):1275-80; discussion 1280. PubMed ID: 17084511
[TBL] [Abstract][Full Text] [Related]
13. Immunocytology in the assessment of patients with painless gross haematuria.
Schmitz-Dräger B; Tirsar LA; Schmitz-Dräger C; Dörsam J; Bismarck E; Ebert T
BJU Int; 2008 Feb; 101(4):455-8. PubMed ID: 18005211
[TBL] [Abstract][Full Text] [Related]
14. Narrow-band imaging flexible cystoscopy in the detection of clinically unconfirmed positive urine cytology.
Zhu YP; Shen YJ; Ye DW; Wang CF; Yao XD; Zhang SL; Dai B; Zhang HL; Shi GH
Urol Int; 2012; 88(1):84-7. PubMed ID: 22104957
[TBL] [Abstract][Full Text] [Related]
15. Atypical squamous cells in exfoliative urinary cytology: clinicopathologic correlates.
Owens CL; Ali SZ
Diagn Cytopathol; 2005 Dec; 33(6):394-8. PubMed ID: 16299739
[TBL] [Abstract][Full Text] [Related]
16. [Value of urinary cytology in the detection and surveillance of tumors of the urinary tract].
Viville C; Fornoff H; Bellocq JP
J Urol (Paris); 1986; 92(5):275-80. PubMed ID: 3782842
[TBL] [Abstract][Full Text] [Related]
17. [Occult urothelial neoplasia: diagnosis].
Pegoraro V; Dal Bianco M; Bassi P; Galetti TP; Cisternino A; Garbeglio A
J Urol (Paris); 1985; 91(2):95-7. PubMed ID: 4008971
[TBL] [Abstract][Full Text] [Related]
18. [Availability of NMP22 (nuclear matrix protein 22) for the diagnosis of urothelial cancer].
Akagashi K; Tanda H; Kato S; Ohnishi S; Nakajima H; Nanbu A; Nitta T; Koroku M
Hinyokika Kiyo; 2001 May; 47(5):307-10. PubMed ID: 11433749
[TBL] [Abstract][Full Text] [Related]
19. Polypoid/papillary cystitis: a series of 41 cases misdiagnosed as papillary urothelial neoplasia.
Lane Z; Epstein JI
Am J Surg Pathol; 2008 May; 32(5):758-64. PubMed ID: 18379418
[TBL] [Abstract][Full Text] [Related]
20. Urine cytology discrepancies: frequency, causes, and outcomes.
Raab SS; Grzybicki DM; Vrbin CM; Geisinger KR
Am J Clin Pathol; 2007 Jun; 127(6):946-53. PubMed ID: 17509992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
